Patent · US Active

Antibodies directed against amyloid-beta peptide and nucleic acids encoding same

US7763250B2 · kind B2 · utility

18Cited by

112References

29Claims

0Family size

Assignee

RINAT NEUROSCIENCE CORP. · US

Inventors

Arnon Rosenthal · Woodside, US
Jaume Pons · San Francisco, US
Wei-Hsien Ho · Belmont, US

Key dates

Filing date	Apr 28, 2006
Grant date	Jul 27, 2010
Priority date	—
Expiry date	Jul 15, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies directed to the C-terminal side of β-amyloid peptide and methods of using these antibodies for diagnosing and treatment of Alzheimer's disease and Aβ peptide associated diseases are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.